Neuroimaging methods are a core component of psychiatric research. They provide a means to assay differences in brain systems that underlie psychiatric illness, treatment response, and properties of brain function that convey risk for disease.
Neuroimaging techniques used by a large percentage of clinical researchers in psychiatry include structural and functional methods based on Magnetic Resonance Imaging (MRI), molecular assays using Positron Emission Tomography (PET), and electrophysiological approaches.
The psychiatric neuroimaging research program comprises a diverse group of laboratories and affiliated initiatives that seek to understand psychiatric illness using neuroimaging approaches. A strength of the program is its broad focus on a range of psychiatric disorders across laboratories, including developmental and adult-onset illnesses. A further strength of the program is that it serves as a nexus linking traditional academic departments with MGH, especially for the areas of psychology and neuroscience, which have a long-standing focus on psychiatric illness.
Learn more about our program:
Members of the Psychiatric Neuroimaging Program.
Imaging tools and stimulation technologies that enable safe exploration of the living human brain.
Taking advantage of the opportunity to explore the effects of multiple genetic variations on specific brain systems and risk for mental illness.
Cross-disciplinary collaboration and training are essential components of neuroimaging research within the MGH Department of Psychiatry.
History of MGH Psychiatric Neuroimaging
Tracing the history of neuroimaging as a tool for psychiatry research.